TCL Archive Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations June 28, 2013Vol.36 No.6
TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013Vol.36 No.6
TCL Archive Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data June 28, 2013Vol.36 No.6
TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013Vol.36 No.6
TCL Archive Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III June 28, 2013Vol.36 No.6
